Climedo
Climedo Health GmbH is a Munich-based HealthTech company selling a validated, GDPR-compliant eClinical SaaS platform — EDC, eCOA/ePRO, eConsent, dashboards, and DCT/wearables — to pharma, biotech, MedTech, CRO, hospital, and public health clients across Europe on a per-study subscription model.
- Company typePrivate
- Founded2017
- HeadquartersMünchen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Climedo does
Climedo Health GmbH is a Munich-based HealthTech company that sells a cloud-based eClinical platform for clinical data capture, targeted at pharmaceutical and biotechnology sponsors, medical device manufacturers, contract research organizations, hospitals, and public health authorities. The platform's core is an Electronic Data Capture (EDC) system extended with electronic Clinical Outcome Assessment / electronic Patient-Reported Outcomes (eCOA/ePRO) for patient-centric data collection, eConsent for digital informed consent, real-time dashboards and visualizations, and Hybrid/DCT (decentralized clinical trial) capabilities including wearables and televisit integration. Supporting features include Smart Fields for automated calculations, source data verification, a sandbox testing environment, randomization, audit trail export, and module-level data linking. The platform is validated to GAMP5, FDA 21 CFR Part 11, EU GMP Annex 11, and ICH GCP, with AWS infrastructure hosted in Frankfurt, Germany and ISO 27001/ISO 9001 certification.
The company operates a B2B SaaS revenue model: customers pay a monthly subscription fee per active clinical study or survey with unlimited user licenses within each study, plus a one-time setup fee scoped to project requirements, with tiered Bronze/Silver/Gold support packages and typical annual billing preceded by an optional pilot. Customer acquisition is primarily direct enterprise sales, supported by content marketing, webinars ("Climedo Connect"), industry events, and an active LinkedIn/social presence; the company self-reports quantified outcomes of 90% patient compliance, 54% higher data quality, and 49% time savings versus paper-based workflows.
Climedo was founded in 2017, has grown to 11–50 employees, and has raised approximately €5 million in seed funding in February 2022 from Nauta Capital (lead), Westtech Ventures, and angel investors, with stated plans to expand across Europe. The product has been continuously developed, with major releases including Version 2.0.0 (Jul 2022), Version 3.0.0 (Nov 2022), Version 4.0.0 (Oct 2023), Version 4.7.0–4.12.0 (2024–2026), reflecting steady investment in multinational trial support, data quality, and decentralized trial workflows.
Climedo firmographics
Firmographics- Name
- Climedo
- Legal name
- Climedo Health GmbH
- Website
- https://climedo.de
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Climedo Health GmbH is a Munich-based HealthTech company selling a validated, GDPR-compliant eClinical SaaS platform — EDC, eCOA/ePRO, eConsent, dashboards, and DCT/wearables — to pharma, biotech, MedTech, CRO, hospital, and public health clients across Europe on a per-study subscription model.
- Ownership category
- akta.pro rank
Climedo industry classification
Industry- Product category
- Clinical Trial Software (eClinical Platform)
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
- akta.pro secondary industries
- Electronic Data Capture (EDC) Platforms (HLACAOAA), Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)
Keywords
Where Climedo is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Climedo business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (Per Study/Survey): Monthly SaaS subscription fee charged per active clinical study or survey. Customers pay per project per month with unlimited user licenses within each study. Includes setup/onboarding fee.
- One-time Setup Fee: One-time instance setup fee for establishing the Climedo environment, dependent on service scope. This is a one-time revenue stream at project initiation.
- Support Services: Customer support included in packages with tiered service levels (Bronze, Silver, Gold). Additional support packages available based on customer needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Custom pricing based on study requirements |
| Subscription | Monthly | Included features across all packages |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Climedo product offering
Product offeringCore offering
Climedo provides a cloud-based eClinical platform delivering integrated Electronic Data Capture (EDC), electronic Clinical Outcome Assessment (ePRO), eConsent, real-time Dashboards, and Hybrid/Decentralized Clinical Trial (DCT) capabilities for clinical research. The platform is used by pharmaceutical, biotech, medical device, and CRO customers to run Phase I-IV intervention studies, non-interventional studies (NIS), and Real-World Evidence (RWE) data collection. It is sold via a per-study SaaS subscription with unlimited user licenses and tiered support packages.
Product overview
Climedo offers a unified eClinical platform for clinical data capture focused on electronic Clinical Outcome Assessment (eCOA). The platform operates on a modular architecture with a core EDC (Electronic Data Capture) system as the foundation, complemented by eCOA/ePRO for patient-reported outcomes, Dashboards & Visualizations for real-time monitoring, eConsent for digital informed consent, and Hybrid/DCT capabilities for decentralized trials. Additional modules include Wearables integration for activity data collection and Smart Fields for automated calculations. The platform is designed for Pharma & Biotech, MedTech, CROs, and Hospitals/Academia, supporting non-interventional studies (NIS), Real-World Evidence (RWE), and traditional Phase I-IV clinical trials. Pricing follows a per-study/per-survey SaaS model with unlimited user licenses.
Differentiator
Problem solved
Functional benefit
Products and services
- EDC (Electronic Data Capture) Cloud-based Electronic Data Capture system for collecting clinical trial data from study sites. Supports non-interventional studies (NIS), Real-World Evidence (RWE) studies, and traditional Phase I-IV clinical trials. Designed for pharmaceutical, biotech, medical device, CRO, and academic research customers.
- eCOA / ePRO Electronic Clinical Outcome Assessment and electronic Patient-Reported Outcomes solution enabling patients to submit clinical data via web or mobile. Supports 90% patient compliance with device-agnostic, location-independent access and automated reminders. Used by pharma, biotech, CRO, and medical device sponsors.
- Dashboards & Visualizations Real-time monitoring dashboards with widgets for patient recruitment, data completion rates, benchmarking across sites, and progression tracking. Includes Progression Widget and Benchmarking Widget for comparing patient data against study population. Used by clinical operations and data management teams.
- eConsent Electronic informed consent module supporting digital document upload, signature workflows, and re-consent tracking. Supports hybrid setting for tracking both paper and electronic consent within the same study, with integration to televisit solutions. Designed for decentralized and hybrid clinical trial use cases.
- Hybrid / DCT (Decentralized Clinical Trials) Decentralized clinical trial capabilities enabling hybrid study designs that combine traditional site visits with remote patient data collection via ePRO, wearables, and telemedicine integration. Designed for sponsors running hybrid or fully decentralized trials.
- Wearables Module Module integrating wearable device data as an additional source of clinical data collection. Collects activity data including step count, distance, heart rate, and sleep duration, displayed per study subject with graphical visualizations. Supports decentralized clinical trial use cases.
Quantifiable outcome
- 90% patient compliance rate
- +2 more outcomes
Companies that use Climedo
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Climedo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature10 records
Climedo partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Climedo competitors and assessment
Company assessmentDirect peers
- Castor EDC: Amsterdam-based eClinical platform offering EDC, eCOA/ePRO, eConsent, and decentralized trial capabilities. Most direct European competitor to Climedo with similar target segments (pharma, biotech, CROs, MedTech) and comparable modular SaaS architecture.
- Clario: Formed via merger of ERT and Bioclinica, Clario is a leading eCOA specialist with deep expertise in clinical outcome assessments, imaging, and wearables. Direct competitor to Climedo's eCOA/ePRO offering, particularly for late-phase and decentralized trials.
- Signant Health: Pure-play eCOA/ePRO provider offering electronic clinical outcome assessments, patient diaries, and eConsent. Direct competitor focused on the same patient-facing data collection niche as Climedo.
- Viedoc: Swedish eClinical platform offering EDC, eCOA/ePRO, eConsent, and RTSM with strong European footprint. Comparable European direct competitor to Climedo with similar modular SaaS architecture and pharma/biotech/CRO customer base.
- Medrio: Cloud-based EDC and eCOA platform serving pharma, biotech, CROs, and MedTech for clinical trials. Direct competitor with similar SaaS model and feature breadth targeting mid-market customers.
Broad incumbents
- Veeva Systems: NYSE-listed leader in life sciences cloud software with Veeva Vault CDB, Vault EDC, Vault ePRO, and Vault CTMS serving global pharma and CROs. Broad incumbent with significantly larger scale, established enterprise customer base, and broader eClinical suite than Climedo.
- Medidata (Dassault Systèmes): Industry-leading RAVE EDC, eCOA, and decentralized trial platform owned by Dassault Systèmes. Broad incumbent serving most top-20 pharma sponsors with deep clinical trial functionality; competes with Climedo for enterprise pharma deals.
- ArisGlobal: Provider of life sciences R&D technology including EDC, clinical trial management, and safety/pharmacovigilance. Broad incumbent competing with Climedo on enterprise clinical trial platform deals.
Emerging players
- OpenClinica: Open-source and commercial EDC platform serving academic, government, and commercial clinical research. Adjacent competitor with overlap on EDC functionality and clinical trial data management.
- YPrime: eClinical solution provider specializing in IRT/RTSM, eCOA, and clinical trial technology. Overlaps with Climedo on eCOA and decentralized trial enablement for mid-sized sponsors and CROs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Climedo social profiles
Digital presenceClimedo compliance and trust
Trust signalCompliance10 records
Climedo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Climedo leadership team
Management profileNumber of profiles
Profiles3 records
Climedo funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Climedo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Climedo
What does Climedo do?
Climedo provides a cloud-based eClinical platform delivering integrated Electronic Data Capture (EDC), electronic Clinical Outcome Assessment (ePRO), eConsent, real-time Dashboards, and Hybrid/Decentralized Clinical Trial (DCT) capabilities for clinical research. The platform is used by pharmaceutical, biotech, medical device, and CRO customers to run Phase I-IV intervention studies, non-interventional studies (NIS), and Real-World Evidence (RWE) data collection. It is sold via a per-study SaaS subscription with unlimited user licenses and tiered support packages.
Is Climedo a public or private company?
Climedo is a private company. It is classified as venture growth investor backed and is currently operating.
When was Climedo founded?
Climedo was founded in 2017. It employs 11 to 50 people.
Where is Climedo based?
Climedo is headquartered in München, Germany, in the Europe region.
How does Climedo make money?
Three revenue lines are on record. SaaS Subscription (Per Study/Survey) is the primary driver. The others are one-time Setup Fee and support Services.
Who are Climedo's main competitors?
Direct peers on record are Castor EDC, Clario, Signant Health, Viedoc and Medrio. Broad incumbents are Veeva Systems, Medidata (Dassault Systèmes) and ArisGlobal. Emerging players are OpenClinica and YPrime.
Does Climedo have an API?
Yes. Climedo offers an API to hybrid elements as indicated in their pricing configuration options. The API enables integration with hybrid/decentralized clinical trial elements. No additional details provided about API type (REST, GraphQL, etc.), authentication method, rate limits, or versioning.
What industry is Climedo in?
Climedo's product category is Clinical Trial Software (eClinical Platform). Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 513210 and its SIC code is 7372.